reports
Hybridan Small Cap Feast - 04 Apr 24
4th April 2024 @HybridanLLP Status of this Note and Disclaimer This document has been issued to you by Hybridan LLP for information purposes only and should not be construed in any circumstances as an offer to sell or solicitation of any offer to buy any security or other financial instrument, nor shall it, or the fact of its distribution, form the basis of, or be relied upon in connection with, any contract relating to such action. This document has no regard for the specific investment objecti...
Hybridan Small Cap Feast - 22 Feb 24
22st February 2024 @HybridanLLP Status of this Note and Disclaimer This document has been issued to you by Hybridan LLP for information purposes only and should not be construed in any circumstances as an offer to sell or solicitation of any offer to buy any security or other financial instrument, nor shall it, or the fact of its distribution, form the basis of, or be relied upon in connection with, any contract relating to such action. This document has no regard for the specific investment obj...
Plant Health Care: 2 directors
Two Directors at Plant Health Care bought 1,141,000 shares at between 3.62p and 3.79p. The significance rating of the trade was 52/100. Is that information sufficient for you to make an investment decision? This report gives details of those trades and adds context and analysis to them such that you can judge whether these trading decisions are ones worth following. Included in the report is a detailed share price chart which plots discretionary trades by all the company's directors over the l...
Hybridan Small Cap Feast - 28 Sep 23
28th September 2023 @HybridanLLP Status of this Note and Disclaimer This document has been issued to you by Hybridan LLP for information purposes only and should not be construed in any circumstances as an offer to sell or solicitation of any offer to buy any security or other financial instrument, nor shall it, or the fact of its distribution, form the basis of, or be relied upon in connection with, any contract relating to such action. This document has no regard for the specific investment ob...
Hybridan Small Cap Feast - 27 Sep 23
27th September 2023 @HybridanLLP Status of this Note and Disclaimer This document has been issued to you by Hybridan LLP for information purposes only and should not be construed in any circumstances as an offer to sell or solicitation of any offer to buy any security or other financial instrument, nor shall it, or the fact of its distribution, form the basis of, or be relied upon in connection with, any contract relating to such action. This document has no regard for the specific investment ob...
Hybridan Small Cap Feast - 18 Aug 23
18th August 2023 The Hybridan Team will take a well earned break today for a few weeks. Back on 4 September. Enjoy the Summer! @HybridanLLP Status of this Note and Disclaimer This document has been issued to you by Hybridan LLP for information purposes only and should not be construed in any circumstances as an offer to sell or solicitation of any offer to buy any security or other financial instrument, nor shall it, or the fact of its distribution, form the basis of, or be relied upon in connec...
Hybridan Small Cap Feast - 23 Jun 23
23rd June 2023 @HybridanLLP Status of this Note and Disclaimer This document has been issued to you by Hybridan LLP for information purposes only and should not be construed in any circumstances as an offer to sell or solicitation of any offer to buy any security or other financial instrument, nor shall it, or the fact of its distribution, form the basis of, or be relied upon in connection with, any contract relating to such action. This document has no regard for the specific investment objecti...
Hybridan Small Cap Feast - 09 May 23
9th May 2023 @HybridanLLP Status of this Note and Disclaimer This document has been issued to you by Hybridan LLP for information purposes only and should not be construed in any circumstances as an offer to sell or solicitation of any offer to buy any security or other financial instrument, nor shall it, or the fact of its distribution, form the basis of, or be relied upon in connection with, any contract relating to such action. This document has no regard for the specific investment objective...
Hybridan Small Cap Feast - 02 May 23
2nd May 2023 @HybridanLLP Status of this Note and Disclaimer This document has been issued to you by Hybridan LLP for information purposes only and should not be construed in any circumstances as an offer to sell or solicitation of any offer to buy any security or other financial instrument, nor shall it, or the fact of its distribution, form the basis of, or be relied upon in connection with, any contract relating to such action. This document has no regard for the specific investment objective...
DGAP-News: Results for the year ended 31 December 2021
DGAP-News: Plant Health Care Results for the year ended 31 December 2021 14.05.2022 / 00:02 The issuer is solely responsible for the content of this announcement. Results for the year ended 31 December 2021Released 07:00:05 12 May 2022RNS Number : 1831LPlant Health Care PLC12 May 2022 Results for the year ended 31 December 2021By 2050 the world will need 60% more foodOur products support sustainable food production by using nature to enable farmers to produce more from less land, whilst protecting soils and biodiversity and reducing reliance on chemical fertilizers. • • Th...
DGAP-News: Plant Health Care, plc
DGAP-News: Plant Health Care Plant Health Care, plc 01.02.2022 / 14:15 The issuer is solely responsible for the content of this announcement. February 1st, 2022 - Plant Health Care(R) (AIM.PHC.L), a leading provider of novel patent-protected biological products to global agriculture markets, announces its trading update for the 12-month period to 31st December. All results provided are preliminary and subject to completion of the 2021 audit. Financial and Commercial highlights:Revenue increased 28% to $8.4m (2020: $6.6m)24% increase in constant currency Gross margin expand...
- Anne Margaret Crow
Plant Health Care - Leading the field
Plant Health Care expects to gain the first US regulatory approval for one of the products in its New Technology portfolio, PHC279, a PREtec (plant response elicitor) in 2020, leading to market launch in 2021. The PREtec products, which address markets worth over US$5bn, complement the company’s existing range of biological products for boosting plant yields, which are already approved for sale in 16 countries.
Ford Equity International Rating and Forecast Report
Ford Equity International Research Reports cover 60 countries with over 30,000 stocks traded on international exchanges. A proprietary quantitative system compares each company to its peers on proven measures of business value, growth characteristics, and investor behavior. Ford's three recommendation ratings buy, hold and sell, represent each stock’s return potential relative to its own country market.. The rating reports which are generated each week, include the fundamental details behind...
Unfortunately, this report is not available for the investor type or country you selected.
Report is subscription only.
Thank you, your report is ready.
Thank you, your report is ready.